No interaction between ciprofloxacin and an oral contraceptive

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 12, 1998, Pages 3266-3268

  Scholten, P C ^a   Droppert, R M ^a   Zwinkels, M G J ^b   Moesker, H L ^c   Nauta, J J P ^c   Hoepelman, I M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Kendle U Gene Research BV   (Netherlands)

^c Bayer BV   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; DESOGESTREL PLUS ETHINYLESTRADIOL; ESTRADIOL; ORAL CONTRACEPTIVE AGENT; PLACEBO; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SEX HORMONE BINDING GLOBULIN;

ADULT; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL CONTRACEPTION; ORAL DRUG ADMINISTRATION; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVULATION INHIBITION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031728653     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.12.3266     Document Type: Article

References (15)

1. Back, D. J., S. F. M. Grimmer, M. L. E. Orme, C. Proudlove, R. D. Mann, and A. M. Breckenridge. 1988. Evaluation of Committee on Safety of Medicines yellow card reports on oral contraceptive-drug interactions with anti-convulsants and antibiotics. Br. J. Clin. Pharmacol. 25:527-532.
2. Back, D. J., and M. L. E. Orme. 1990. Pharmacokinetic drug interactions with oral contraceptives. Clin. Pharmacokinet. 18:472-484.
3. Bayer AG. 1989. Harmonisation of data evaluation in pharmacokinetics - a task force report. 5747 (P). Bayer AG, Leverkusen, Germany.
4. British Medical Journal. 1980. Drug interactions with oral contraceptive steroids. Br. Med. J. 6233:93-94. (Editorial.)
5. Csemiczky, G., C. Alvendal, and B. M. Landgren. 1996. Risk for evaluation in women taking a low-dose oral contraceptive (Microgynon) when receiving antibacterial treatment with a fluoroquinolone (ofloxacin). Adv. Contracept. 12:101-109.
6. D'Arcy, P. F. 1986. Drug interactions with oral contraceptives. Drug Intell. Clin. Pharm. 20:353-362.
7. Nocke-Finck, L., H. Breuer, and D. Reimers. 1973. Effects of antibiotics on oestrogen excretion in women taking oral contraceptives. Acta Endocrinol. 177(Suppl.):136.
8. Reimers, D., and A. Jezek. 1971. Rifampicin und andere Antituberkulotika bei gleichzeitiger oraler Kontrazeption. Prax. Pneumol. 25:255-262.
9. Scholl, H., K. Schmidt, and B. Weber. 1987. Sensitive and selective determination of picogram amounts of ciprofloxacin and its metabolites in biological samples using high-performance liquid chromatography and photothermal post-column derivatization. J. Chromatogr. 416:321-330.
10. Schuirmann, D. J. 1987. A comparison of the two one-sided tests procedure and the power approach for assessing the equivalence of average bioavailability. J. Pharmacokinet. Biopharm. 15:657-680.
11. Skolnick, J. L., B. S. Stoler, D. B. Katz, and W. H. Anderson. 1976 Rifampicin, oral contraceptives, and pregnancy. JAMA 236:1382.
12. Sparrow, M. J. 1987. Pill method failures. N. Z. Med. J. 100:102-105.
13. Sparrow, M. J. 1989. Pregnancies in reliable pill takers. N. Z. Med. J. 102: 575-577.
14. Szoka, P. R., and R. A. Edgren. 1988. Drug interactions with oral contraceptives: compilation and analysis of an adverse experience report database. Fertil. Steril. 49(Suppl.):31S-39S.
15. van der Kuy, A., and J. M. W. M. Merkus. 1989. The interaction between OAC and antibiotics. J. Drug Ther. Res. 14:255-256.